Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...
In a groundbreaking study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs diseases—two rare, often fatal lysosomal storage disorders that cause ...
The second module submitted earlier this week for the RefluxStoptm PMA is the most crucial module of the three-module process for FDA approval. The outcome of our clinical study submitted to FDA shows ...
A primary benefit of the FDA Fast Track designation is how it accelerates the drug approval process. Early and continuous ...
At this time, all participants are in a listen-only mode. Later, there will be a question-and-answer session, and instructions will be given at that time. Please note that today's call is being ...
BEDFORD, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback